Europe Real World Evidence Solutions Market

Europe Real World Evidence Solutions Market Size, Share & Industry Trends Analysis Report By Component, By Therapeutic Area, By End-user (Healthcare Companies, Healthcare Payers, Healthcare Providers), By Application, By Country and Growth Forecast, 2022 - 2028

Report Id: KBV-13503 Publication Date: January-2023 Number of Pages: 110
Special Offering:
Industry Insights | Market Trends
Highest number of Tables | 24/7 Analyst Support
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Real World Evidence Solutions Market, by Component
1.4.2 Europe Real World Evidence Solutions Market, by Therapeutic Area
1.4.3 Europe Real World Evidence Solutions Market, by End-user
1.4.4 Europe Real World Evidence Solutions Market, by Application
1.4.5 Europe Real World Evidence Solutions Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Scenario and Composition
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Strategies Deployed in Real World Evidence Solutions Market

Chapter 4. Europe Real World Evidence Solutions Market by Component
4.1 Europe Services Market by Country
4.2 Europe Data Set Market by Country

Chapter 5. Europe Real World Evidence Solutions Market by Therapeutic Area
5.1 Europe Oncology Market by Country
5.2 Europe Cardiology Market by Country
5.3 Europe Neurology Market by Country
5.4 Europe Diabetes Market by Country
5.5 Europe Respiratory Market by Country
5.6 Europe Others Market by Country

Chapter 6. Europe Real World Evidence Solutions Market by End-user
6.1 Europe Healthcare Companies Market by Country
6.2 Europe Healthcare Payers Market by Country
6.3 Europe Healthcare Providers Market by Country
6.4 Europe Others Market by Country

Chapter 7. Europe Real World Evidence Solutions Market by Application
7.1 Europe Drug Development & Approvals Market by Country
7.2 Europe Medical Device Development & Approvals Market by Country
7.3 Europe Reimbursement/Coverage & Regulatory Decision Making Market by Country
7.4 Europe Post Market Safety & Adverse Events Monitoring Market by Country

Chapter 8. Europe Real World Evidence Solutions Market by Country
8.1 Germany Real World Evidence Solutions Market
8.1.1 Germany Real World Evidence Solutions Market by Component
8.1.2 Germany Real World Evidence Solutions Market by Therapeutic Area
8.1.3 Germany Real World Evidence Solutions Market by End-user
8.1.4 Germany Real World Evidence Solutions Market by Application
8.2 UK Real World Evidence Solutions Market
8.2.1 UK Real World Evidence Solutions Market by Component
8.2.2 UK Real World Evidence Solutions Market by Therapeutic Area
8.2.3 UK Real World Evidence Solutions Market by End-user
8.2.4 UK Real World Evidence Solutions Market by Application
8.3 France Real World Evidence Solutions Market
8.3.1 France Real World Evidence Solutions Market by Component
8.3.2 France Real World Evidence Solutions Market by Therapeutic Area
8.3.3 France Real World Evidence Solutions Market by End-user
8.3.4 France Real World Evidence Solutions Market by Application
8.4 Russia Real World Evidence Solutions Market
8.4.1 Russia Real World Evidence Solutions Market by Component
8.4.2 Russia Real World Evidence Solutions Market by Therapeutic Area
8.4.3 Russia Real World Evidence Solutions Market by End-user
8.4.4 Russia Real World Evidence Solutions Market by Application
8.5 Spain Real World Evidence Solutions Market
8.5.1 Spain Real World Evidence Solutions Market by Component
8.5.2 Spain Real World Evidence Solutions Market by Therapeutic Area
8.5.3 Spain Real World Evidence Solutions Market by End-user
8.5.4 Spain Real World Evidence Solutions Market by Application
8.6 Italy Real World Evidence Solutions Market
8.6.1 Italy Real World Evidence Solutions Market by Component
8.6.2 Italy Real World Evidence Solutions Market by Therapeutic Area
8.6.3 Italy Real World Evidence Solutions Market by End-user
8.6.4 Italy Real World Evidence Solutions Market by Application
8.7 Rest of Europe Real World Evidence Solutions Market
8.7.1 Rest of Europe Real World Evidence Solutions Market by Component
8.7.2 Rest of Europe Real World Evidence Solutions Market by Therapeutic Area
8.7.3 Rest of Europe Real World Evidence Solutions Market by End-user
8.7.4 Rest of Europe Real World Evidence Solutions Market by Application

Chapter 9. Company Profiles
9.1 IBM Corporation
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Regional & Segmental Analysis
9.1.4 Research & Development Expenses
9.1.5 Recent strategies and developments:
9.1.5.1 Acquisition and Mergers:
9.1.6 SWOT Analysis
9.2 Oracle Corporation
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expense
9.2.5 SWOT Analysis
9.3 PPD, Inc. (Thermo Fisher Scientific, Inc.)
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expense
9.3.5 SWOT Analysis
9.4 UnitedHealth Group, Inc. (Optum, Inc.)
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Segmental Analysis
9.5 Syneos Health, Inc.
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental and Regional Analysis
9.5.4 Recent strategies and developments:
9.5.4.1 Acquisition and Mergers:
9.6 IQVIA Holdings, Inc.
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Segmental and Regional Analysis
9.6.4 Recent strategies and developments:
9.6.4.1 Partnerships, Collaborations, and Agreements:
9.6.4.2 Acquisition and Mergers:
9.7 Medpace Holdings, Inc.
9.7.1 Company Overview
9.7.2 Financial Analysis
9.8 ICON plc
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Regional Analysis
9.8.4 Recent strategies and developments:
9.8.4.1 Acquisition and Mergers:
9.9 PerkinElmer, Inc.
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Segmental and Regional Analysis
9.9.4 Research & Development Expense
9.9.5 Recent strategies and developments:
9.9.5.1 Product Launches and Product Expansions:
9.10. Parexel International Corporation (Phoenix Parentco, Inc.)
9.10.1 Company Overview
9.10.2 Recent strategies and developments:
9.10.2.1 Partnerships, Collaborations, and Agreements:
HAVE A QUESTION?

HAVE A QUESTION?

Call: +1(646) 600-5072

SPECIAL PRICING & DISCOUNTS


  • Buy Sections of This Report
  • Buy Country Level Reports
  • Request for Historical Data
  • Discounts Available for Start-Ups & Universities

Unique Offerings Unique Offerings


  • Exhaustive coverage
  • The highest number of Market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Support with 10% customization free after sale

Trusted by over
5000+ clients

Our team of dedicated experts can provide you with attractive expansion opportunities for your business.

Client Logo